Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu

Phase I/II Study Evaluating AUTO4 in Patients With TRBC1 Positive T Cell Lymphoma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03590574
Recruitment Status : Recruiting
First Posted : July 18, 2018
Last Update Posted : July 3, 2019
Sponsor:
Information provided by (Responsible Party):
Autolus Limited

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Recruiting
  Estimated Primary Completion Date : July 2021
  Estimated Study Completion Date : December 2022